EMD-49549

Single-particle
2.38 Å
EMD-49549
3D View Gallery
Deposition: 04/03/2025
Map released: 14/01/2026
Last modified: 14/01/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-49549

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Constituent EM map: Focused refinement on TaF/TMD/CTD of mouse RyR1 with simvastatin (Ca2+/CFF/ATP dataset; closed pore)

EMD-49549

Single-particle
2.38 Å
EMD-49549
3D View Gallery
Deposition: 04/03/2025
Map released: 14/01/2026
Last modified: 14/01/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Mus musculus
Sample: Complex of RyR1 with Calstabin-1 in presence of simvastatin (Ca2+/CFF/ATP condition)

Deposition Authors: Weninger G, Marks AR
Structural basis for simvastatin-induced skeletal muscle weakness associated with type 1 ryanodine receptor T4709M mutation.
Weninger G, Dridi H, Reiken S, Yuan Q, Zhao N, Groom L, Leigh J, Liu Y, Tchagou C, Kang J, Chang A, Luna-Figueroa E, Miotto MC, Wronska A, Dirksen RT, Marks AR
(2025) J Clin Inv , 135
PUBMED: 41392983
DOI: doi:10.1172/JCI194490
ISSN: 0021-9738
ASTM: JCINAO